Pulse Biosciences (PLSE) Announces Timing of $60M Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
May 2, 2024 8:00 AM EDTHAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE) (Pulse or the Company), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation (nsPFA) technology, today announced that the Companys Board of Directors has set the record date for the Companys previously announced rights offering (the Rights Offering), which will be available to all holders of record of the Companys common stock, par value $0.001 per share (the Common Stock), as of the close of the market on Thursday, May 16, 2024 (the Record Date).
The Company intends to distribute to all holders of Common... More
